GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.060
+0.050 (1.66%)
Nov 22, 2024, 4:00 PM EST - Market closed
GT Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -12.35 | -7.6 | -20.88 | -58.01 | -28.3 | -38.65 | Upgrade
|
| Depreciation & Amortization | - | - | - | - | - | 0 | Upgrade
|
| Other Amortization | - | - | - | - | 0.32 | 0.51 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 20.49 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.06 | 4.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0 | -0.05 | 0.03 | 0.03 | - | - | Upgrade
|
| Stock-Based Compensation | 0.66 | 2.2 | 7.65 | 33.93 | 0.27 | 5.31 | Upgrade
|
| Other Operating Activities | -0.78 | -5.23 | -0.02 | 0.51 | 17.98 | - | Upgrade
|
| Change in Accounts Payable | 0.29 | 1.96 | -2.03 | 7.08 | -0.84 | 3.15 | Upgrade
|
| Change in Other Net Operating Assets | -0.29 | -0.14 | 0.04 | 0.86 | 3.24 | 0.92 | Upgrade
|
| Operating Cash Flow | -12.48 | -8.85 | -15.22 | -15.61 | -7.26 | -3.66 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.2 | Upgrade
|
| Investment in Securities | 13.37 | -2.01 | 12.15 | -23.04 | - | - | Upgrade
|
| Investing Cash Flow | 13.37 | -2.01 | 12.15 | -23.04 | - | 0.2 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 1.21 | 12.53 | 3.53 | Upgrade
|
| Total Debt Issued | - | - | - | 1.21 | 12.53 | 3.53 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.1 | Upgrade
|
| Total Debt Repaid | - | - | - | - | - | -0.1 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 1.21 | 12.53 | 3.43 | Upgrade
|
| Issuance of Common Stock | 2.98 | 6.27 | - | 41.11 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -0.22 | - | - | - | Upgrade
|
| Financing Cash Flow | 2.98 | 6.27 | -0.22 | 42.32 | 12.53 | 3.43 | Upgrade
|
| Net Cash Flow | 3.86 | -4.59 | -3.3 | 3.67 | 5.27 | -0.03 | Upgrade
|
| Free Cash Flow | -12.48 | -8.85 | -15.22 | -15.61 | -7.26 | -3.66 | Upgrade
|
| Free Cash Flow Per Share | -7.44 | -6.57 | -14.33 | -16.63 | -49.68 | -32.44 | Upgrade
|
| Cash Interest Paid | 0.21 | 0.21 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -7.04 | -4.7 | -10.91 | -0.82 | -3.42 | 0.23 | Upgrade
|
| Unlevered Free Cash Flow | -7.04 | -4.57 | -10.9 | -0.38 | -1.66 | 1.06 | Upgrade
|
| Change in Net Working Capital | 0.64 | -1.72 | 5.26 | -1.64 | -2.29 | -2.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.